Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Beckett

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 3, 2018
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosaRaksha Jain, V V Beckett, M W Konstan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 26, 2017
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosisD R VanDevanter, S L Heltshe, J Spahr, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 2, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary ExacerbationsNatalie E West, Valeria V Beckett, Raksha Jain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbationsDon B Sanders, George M Solomon, Valeria V Beckett, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 3, 2018
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosaRaksha Jain, V V Beckett, M W Konstan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 26, 2017
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosisD R VanDevanter, S L Heltshe, J Spahr, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 2, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary ExacerbationsNatalie E West, Valeria V Beckett, Raksha Jain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbationsDon B Sanders, George M Solomon, Valeria V Beckett, et al.
Pageof 2